| 11534394 |
Pharmaceutical composition containing botulinum neurotoxin |
Mary White, Julie Partington |
2022-12-27 |
| 11234987 |
Isoxazole compounds as inhibitors of heat shock proteins |
Martin James Drysdale, Brian William Dymock, Harry Finch, Edward McDonald, Karen Elizabeth James +2 more |
2022-02-01 |
| 10696652 |
Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activity |
Stephen Stokes, Nicolas Foloppe, Andrea Fiumana, Martin James Drysdale, Simon Bedford |
2020-06-30 |
| 10561604 |
Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose |
Mary White, Julie Partington |
2020-02-18 |
| 10413550 |
Isoxazole compounds as inhibitors of heat shock proteins |
Martin James Drysdale, Brian William Dymock, Harry Finch, Edward McDonald, Karen Elizabeth James +2 more |
2019-09-17 |
| 9890100 |
Continuous process for the production of low molecular weight polyethers with a DMC catalyst |
Jack R. Reese |
2018-02-13 |
| 9757329 |
Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose |
Mary White, Julie Partington |
2017-09-12 |
| 9718793 |
Isoxazole compounds as inhibitors of heat shock proteins |
Martin James Drysdale, Brian William Dymock, Harry Finch, Edward McDonald, Karen Elizabeth James +2 more |
2017-08-01 |
| 9604975 |
Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activity |
Stephen Stokes, Nicolas Foloppe, Andrea Fiumana, Martin James Drysdale, Simon Bedford |
2017-03-28 |
| 9125804 |
Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose |
Mary White, Julie Partington |
2015-09-08 |
| 8916591 |
Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activity |
Stephen Stokes, Nicolas Foloppe, Andrea Fiumana, Martin James Drysdale, Simon Bedford |
2014-12-23 |
| 8853106 |
Phosphorus-contaning flame-retardant compositions |
David Malcolm Lewis, Jamie Anthony Hawkes, Andrew Bayliff |
2014-10-07 |
| 8551371 |
Method and composition |
Jamie Anthony Hawkes, David Malcolm Lewis, Andrew Bayliff |
2013-10-08 |
| 8507480 |
Isoxazole compounds as inhibitors of heat shock proteins |
Martin James Drysdale, Brian William Dymock, Harry Finch, Edward McDonald, Karen Elizabeth James +2 more |
2013-08-13 |
| 8450310 |
Isoxazole compounds as inhibitors of heat shock proteins |
Martin James Drysdale, Brian William Dymock, Harry Finch, Edward McDonald, Karen Elizabeth James +2 more |
2013-05-28 |
| 7790680 |
Stable pharmaceutical composition containing factor VIII |
Mary White |
2010-09-07 |
| 7705027 |
Isoxazole compounds as inhibitors of heat shock proteins |
Martin James Drysdale, Brian William Dymock, Harry Finch, Edward McDonald, Karen Elizabeth James +2 more |
2010-04-27 |
| 7302347 |
Method for creating specific, high affinity nuclear receptor pharmaceuticals |
John D. Baxter, Thomas S. Scanlan, Robert J. Fetterick, Sabine Borngraeber |
2007-11-27 |
| 6884577 |
Methods for screening compounds for estrogenic activity |
Peter J. Kushner, Renee Williard, C. Anthony Hunt, Gabriella Lopez |
2005-04-26 |
| 6156723 |
Compositions comprising inhibitors of estrogen response |
Peter J. Kushner, Renee Williard, C. Anthony Hunt, Gabriella Lopez |
2000-12-05 |
| 6117638 |
Methods to screen for transcription factor-coactivator interactions |
Peter J. Kushner, Rosalie M. Uht |
2000-09-12 |
| 5723291 |
Methods for screening compounds for estrogenic activity |
Peter J. Kushner, Renee Williard, C. Anthony Hunt, Gabriella Lopez |
1998-03-03 |
| 5117021 |
Method for purification of tellurium and selenium alkyls |
John B. Mullin, David John Cole-Hamilton, Deodatta Vinayak Shenai-Khatkhate |
1992-05-26 |
| 5091570 |
Method for preparation of dialkyl tellurium and dialkyl selenium |
John B. Mullin, David John Cole-Hamilton, Deodatta Vinayak Shenai-Khatkhate |
1992-02-25 |
